Douglas Todd: Beware the promises of vastly funded psychedelics, warn two Canadian researchers

At the heart of North America’s “renaissance” in psychedelics "is a vast new supply of funding” from big-money interests, says a top Canadian researcher at Harvard Medical School who spoke at a major Vancouver conference